SwingTrade Member Forum

[Rawnoc]

REPR 2/14/10 update...

REPR = Sleeping giant IMO. 2010 going to be a breakout year IMO. They have built an arsenal to manufacture while still maintaining profitability and have stepped up their sales and marketing efforts big time. All costs are already absorbed so big profits await IMO.

All time record sales last quarter for their core product Freedom60.

Some tidbits from the last 10Q:

"We believe the Freedom60 continues to find a solid following in the subcutaneous immune globulin market and this market is expected to continue to increase both domestically and internationally. We continued to experience an increase in sales and cash during nine months ended November 30, 2009 and with these increases and the capital we currently have, we will continue to meet or exceed the company's financial needs for the next twelve months."

"In this quarter ending November 30, 2009 for the Freedom60 line we exhibited at the ECI conference on Immunology in Berlin in October and also at the Medica Trade show in Dusseldorf, Germany. We exhibited at the EMS Expo Trade show in Atlanta in October 2009 to support our RES-Q-VAC in the emergency market."

I think REPR will be getting .02/.03 quarters once their FDA approval is in and their production shifts are up to speed. +.08-.12 EPS annual pace, $1.00 - $2.00 target imo